Organic compounds -- part of the class 532-570 series – Organic compounds – Oxygen containing
Reexamination Certificate
2006-11-14
2006-11-14
Carr, Deborah D. (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Oxygen containing
C568S583000, C568S589000, C568S592000, C568S626000, C568S659000, C514S715000, C514S716000, C514S717000, C514S727000, C514S728000, C514S736000
Reexamination Certificate
active
07135600
ABSTRACT:
The present invention relates to novel compounds of Formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
REFERENCES:
patent: 3994974 (1976-11-01), Murakami et al.
patent: 4730008 (1988-03-01), Skidmore et al.
patent: 4853381 (1989-08-01), Finch et al.
patent: 4853382 (1989-08-01), Skidmore et al.
patent: 4908386 (1990-03-01), Finch et al.
patent: 4937268 (1990-06-01), Skidmore et al.
patent: 4963564 (1990-10-01), Skidmore et al.
patent: 4990505 (1991-02-01), Skidmore et al.
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 4997986 (1991-03-01), Mitchell et al.
patent: 5099068 (1992-03-01), Mitchell et al.
patent: 5109023 (1992-04-01), Mitchell et al.
patent: 5283262 (1994-02-01), Mitchell et al.
patent: 69715 (1983-01-01), None
patent: 162576 (1985-11-01), None
patent: 220054 (1987-04-01), None
patent: 220878 (1987-05-01), None
patent: 223410 (1987-05-01), None
patent: 286242 (1988-10-01), None
patent: 303465 (1989-02-01), None
patent: 317206 (1989-05-01), None
patent: 0416951 (1991-03-01), None
patent: 2064336 (1981-06-01), None
patent: 2129691 (1984-05-01), None
patent: 2140800 (1984-12-01), None
patent: 2159151 (1985-11-01), None
patent: 2162842 (1986-02-01), None
patent: 2169265 (1986-07-01), None
patent: 2178965 (1987-02-01), None
patent: 2242134 (1991-09-01), None
patent: WO 95/01170 (1995-01-01), None
patent: WO 99/16766 (1999-04-01), None
patent: WO 99/47505 (1999-09-01), None
patent: WO 01/13953 (2001-03-01), None
Thornber, “Isosterism and molecular modification in drug design,”Chemical Society Reviews:8(4)563-580 (1979).
Fuji et al., “Novel phosphodiesterase 4 inhibitor T-440 reverses and prevents human bronchial contraction induced by allergen,”J Pharmacol Exp Ther284(1):162 (1998).
Landells et al., “Oral administration of the phosphodiesterase (PDE)4 inhibitor, V11294A inhibits ex-vivo agonist-induced-cell activation,”Eur Resp J(/annu Cong Eur Resp Soc, Geneva) 12(Suppl. 28) Abst P2393 (Sep. 1998).
McHale et al., “Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in Phosphodiesterase-deficient yeast,”Mol Pharmacol39:109-113 (1991).
Nicholson et al., “Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes,”Trends Pharmacol Sci12:19-27 (1991).
Torphy et al., “Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis,”Mol. Pharmacol39:376-384 (1991).
U.S. Appl. No. 10/472,343, filed Mar. 5, 2004, Keith Biggadike et al.
Biggadike Keith
Coe Diane Mary
Guntrip Stephen Barry
Looker Brian Edgar
Procopiou Panayiotis Alexandrou
Carr Deborah D.
Glaxo Group Limited
Smith Robert J.
LandOfFree
Phenethanolamine derivatives for treatment of respiratory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenethanolamine derivatives for treatment of respiratory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenethanolamine derivatives for treatment of respiratory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3631921